Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
47,290,010
-
Shares change
-
+926,780
-
Total reported value, excl. options
-
$332,084,902
-
Value change
-
-$7,111,865
-
Put/Call ratio
-
21%
-
Number of buys
-
62
-
Number of sells
-
-74
-
Price
-
$7.02
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2021
172 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q4 2021.
AERIE PHARMACEUTICALS INC - COM (AERI) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,290,010 shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4,695,020 shares), MORGAN STANLEY (4,031,413 shares), BlackRock Inc. (3,386,015 shares), VANGUARD GROUP INC (3,381,368 shares), Jefferies Group LLC (2,376,000 shares), BANK OF AMERICA CORP /DE/ (2,353,887 shares), AMERIPRISE FINANCIAL INC (2,028,755 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,807,563 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1,352,954 shares), and Granahan Investment Management, LLC (1,238,883 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.